New study aims to improve mobility for millions with flat foot and knee osteoarthritis
The launch of the study was on the occasion of the International Day of Persons with Disabilities
The launch of the study was on the occasion of the International Day of Persons with Disabilities
The Vital Shape panels provide tiered assessments to detect obesity-related risks early
It's an acquisition that aims at forming one of the US's largest oncology trial networks
Biocon will acquire the residual stake held by Mylan (Viatris) for a total consideration of US$ 815 million
Growing patent filings and tier-2 innovators reflect expanding national research base
DBT and BIRAC have partnered with CEPI since 2019, for cooperation on vaccine development for diseases of epidemic potential
The partnership aims to combine TQx’s in vivo therapeutic expertise with Kytopen’s continuous flow transfection technology
The BlueSeal Horizon 3.0T platform incorporates advanced magnet technology
Jaypirca is the first and only FDA-approved non-covalent (reversible) BTK inhibitor
Subscribe To Our Newsletter & Stay Updated